UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Case-Control Study of Aspirin Use and Risk of Pancreatic Cancer

Cancer epidemiology, biomarkers & prevention, 2014-07, Vol.23 (7), p.1254-1263

2014

Volltextzugriff (PDF)

Helicobacter pylori Seropositivities and Risk of Pancreatic Carcinoma

Cancer epidemiology, biomarkers & prevention, 2014-01, Vol.23 (1), p.172-178

2014

Volltextzugriff (PDF)

PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

European journal of nuclear medicine and molecular imaging, 2020-04, Vol.47 (4), p.895-906

2020

Volltextzugriff (PDF)

Aspirin Use and Reduced Risk of Pancreatic Cancer

Cancer epidemiology, biomarkers & prevention, 2017-01, Vol.26 (1), p.68-74

2017

Volltextzugriff (PDF)

Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer

Pancreas, 2011-07, Vol.40 (5), p.657-663

2011

Volltextzugriff (PDF)

Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis

American journal of epidemiology, 2015-07, Vol.182 (1), p.26-34

2015

Volltextzugriff (PDF)

ABO Blood Group, Helicobacter pylori Seropositivity, and Risk of Pancreatic Cancer: A Case–Control Study

JNCI : Journal of the National Cancer Institute, 2010-04, Vol.102 (7), p.502-505

2010

Volltextzugriff (PDF)

Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer"

American journal of epidemiology, 2015-07, Vol.182 (1), p.39-40

2015

Volltextzugriff (PDF)

PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy

European journal of nuclear medicine and molecular imaging, 2018-07, Vol.45 (7), p.1155-1169

2018

Volltextzugriff (PDF)

Inefficacy of chromogranin a assays as neuroendocrine tumor diagnostic tools compared to the NETest

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4612-4612

2020

Volltextzugriff (PDF)

The utility of blood-based molecular tools-the NETest-to monitor and evaluate the efficacy of PRRT in neuroendocrine tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3568-3568

2020

Volltextzugriff (PDF)

A multi-gene colorectal cancer liquid biopsy with >90% accuracy in diagnosis and assessment of disease status

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16079-e16079

2020

Volltextzugriff (PDF)

A 13-gene colorectal cancer liquid biopsy with greater than 90 percent accuracy in diagnosis and assessment of disease status

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.18-18

2020

Volltextzugriff (PDF)

Blood neuroendocrine tumor gene cluster analysis to predict somatostatin analog response

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.276-276

2016

Volltextzugriff (PDF)

A blood-based multi-mRNA liquid biopsy with >90% accuracy for diagnosis and assessment of prostate cancers

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.5574-5574

2020

Volltextzugriff (PDF)

A genomic blood test (NETest) identifies neuroendocrine transformation of prostate cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e17511-e17511

2020

Volltextzugriff (PDF)

Clinical utility of blood derived gene cluster analysis of neuroendocrine tumors using neoplasia hallmark criteria

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15193-e15193

2015

Volltextzugriff (PDF)

Etctn 10388: A phase I trial of triapine and lutetium Lu 177 dotatate in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS4660-TPS4660

2020

Volltextzugriff (PDF)

Blood measurements of neuroendocrine tumor (NET) transcripts and gene cluster analysis to predict efficacy of peptide radioreceptor therapy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4091-4091

2017

Volltextzugriff (PDF)

Surgery in combination with peptide receptor radionuclide therapy is effective in metastatic neuroendocrine tumors and is definable by blood gene transcript analysis

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e15697-e15697

2017

Volltextzugriff (PDF)

A multitranscript blood neuroendocrine tumor molecular signature to identify treatment efficacy and disease progress

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4137-4137

2013

Volltextzugriff (PDF)

Neuroendocrine gene transcript analysis of blood to define the completeness of surgical resection and identify stable or progressive neuroendocrine tumor disease

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.293-293

2015

Volltextzugriff (PDF)

Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of 177 lu-octreotate efficacy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.4101-4101

2018

Volltextzugriff (PDF)

Circulating neuroendocrine transcripts and gene cluster analysis to predict the efficacy of peptide radioreceptor therapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4098-4098

2016

Volltextzugriff (PDF)

A multi-transcript blood signature for detection and assessment of gut neuroendocrine tumors

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.216-216

2014

Volltextzugriff (PDF)

1 – 25 von 872

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(629)
Mit Volltextzugriff
(753)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(389)
Life Sciences & Biomedicine
(347)
Humans
(281)
Female
(119)
Male
(113)
Biological And Medical Sciences
(107)
Medical Sciences
(74)
Middle Aged
(74)
Animals
(66)
Adult
(65)
Tumors
(64)
Oncology
(58)
Aged
(57)
Carcinoid
(51)
Surgery
(49)
Gastroenterology & Hepatology
(45)
Fundamental And Applied Biological Sciences. Psychology
(39)
Gastroenterology And Hepatology
(39)
Endocrinology & Metabolism
(38)
Medicine
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Case-Control Study of Aspirin Use and Risk of Pancreatic Cancer

Helicobacter pylori Seropositivities and Risk of Pancreatic Carcinoma

PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

Aspirin Use and Reduced Risk of Pancreatic Cancer

Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer

Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis

ABO Blood Group, Helicobacter pylori Seropositivity, and Risk of Pancreatic Cancer: A Case–Control Study

Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer"

PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy

Inefficacy of chromogranin a assays as neuroendocrine tumor diagnostic tools compared to the NETest

The utility of blood-based molecular tools-the NETest-to monitor and evaluate the efficacy of PRRT in neuroendocrine tumors

A multi-gene colorectal cancer liquid biopsy with >90% accuracy in diagnosis and assessment of disease status

A 13-gene colorectal cancer liquid biopsy with greater than 90 percent accuracy in diagnosis and assessment of disease status

Blood neuroendocrine tumor gene cluster analysis to predict somatostatin analog response

A blood-based multi-mRNA liquid biopsy with >90% accuracy for diagnosis and assessment of prostate cancers

A genomic blood test (NETest) identifies neuroendocrine transformation of prostate cancer

Clinical utility of blood derived gene cluster analysis of neuroendocrine tumors using neoplasia hallmark criteria

Etctn 10388: A phase I trial of triapine and lutetium Lu 177 dotatate in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Blood measurements of neuroendocrine tumor (NET) transcripts and gene cluster analysis to predict efficacy of peptide radioreceptor therapy

Surgery in combination with peptide receptor radionuclide therapy is effective in metastatic neuroendocrine tumors and is definable by blood gene transcript analysis

A multitranscript blood neuroendocrine tumor molecular signature to identify treatment efficacy and disease progress

Neuroendocrine gene transcript analysis of blood to define the completeness of surgical resection and identify stable or progressive neuroendocrine tumor disease

Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of 177 lu-octreotate efficacy

Circulating neuroendocrine transcripts and gene cluster analysis to predict the efficacy of peptide radioreceptor therapy

A multi-transcript blood signature for detection and assessment of gut neuroendocrine tumors

Suchergebnisse filtern